Regeneron Gets Emergency U.S. Clearance for Covid-19 Therapy

Regeneron Pharmaceuticals Inc.’s antibody cocktail received an emergency-use authorization from U.S. drug regulators for treatment of early Covid-19 symptoms, adding to the expanding arsenal of therapies available to physicians at a time when the virus is surging.

Regeneron’s treatment was given to President Donald Trump last month after he contracted Covid-19. While Trump received a number of drugs to combat the virus, he said after he was released from the hospital he expected speedy authorization of Regeneron’s therapy, crediting it with his recovery.